Annotation Detail for CELA1

Basic Information
Top
Desease ID | Desease Name |
---|
1727 | Pancreas disease |
1904 | Diabetes mellitus |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of CELA1 mRNA | affects expression | 16483693
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of CELA1 mRNA | decreases expression | 20059764
|
C006253 |
pirinixic acid |
PPARA protein promotes the reaction [pirinixic acid results in decreased expression of CELA1 mRNA] | decreases expression|increases reaction | 20059764
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of CELA1 mRNA | decreases expression | 18172886
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.59 | 11752688 15322242 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.30 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.64 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
12.51 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
12.51 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.39 | 11748828 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
10.42 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
10.42 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.66 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
3.02 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.66 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.16 | 16835633 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.58 | 18670907 18850075 16120746 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.58 | 16835633 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.15 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.25 | 15668235 8697196 12621046 16354765 15340226 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.48 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.27 | 20055451 15322242 10048152 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.59 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.74 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.62 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
3.09 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
8.18 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
8.18 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.77 | 18230668 15322242 16714409 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.47 | 10568697 9294722 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.34 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
3.25 | 20131406 19236843 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
4.11 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.60 | 20067830 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.46 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.53 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.78 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.82 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
10.53 | 19176532 18467677 19772884 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
10.53 | 12621046 16120746 15340226 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.91 | 8697196 15340226 16354765 18606429 16959395 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.63 | 20558911 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
2.03 | 18850075 18670907 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
2.04 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.90 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.82 | 16580747 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.24 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.24 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.69 | 16377806 15890375 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.69 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.35 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
1.24 | 19555203 11884234 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
4.16 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.29 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.38 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.29 | 16411023 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.12 | 17405874 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.80 | 14600291 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.89 | 20558911 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
5.12 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
4.14 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.93 | 11896295 11222880 11399792 11118676 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.56 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.42 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.21 | 16192470 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.77 | 12697716 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.46 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
5.12 | 15886252 |
Drugbank ID |
Action |
Drug Name |
Description |
---|
DB01844 |
- |
Dimethylformamide |
|
DB02114 |
- |
Para-Isopropylaniline |
|
DB02341 |
- |
Mdl 101,146 |
|
DB03202 |
- |
2-[5-Methanesulfonylamino-2-(4-Aminophenyl)-6-Oxo-1,6-Dihydro-1-Pyrimidinyl]-N-(3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl)Acetamide |
|
DB03702 |
- |
2-[4-[[(S)-1-[[(S)-2-[[(Rs)-3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl]Aminocarbonyl]Pyrrolidin-1-Yl-]Carbonyl]-2-Methylpropyl]Aminocarbonyl]Benzoylamino]Acetic Acid |
Elastase 1 inhibitor |
DB03757 |
- |
(Tert-Butyloxycarbonyl)-Alanyl-Alanyl-Amine |
|
DB03890 |
- |
N-[2-(1-Formyl-2-Methyl-Propyl)-1-(4-Piperidin-1-Yl-but-2-Enoyl)-Pyrrolidin-3-Yl]-Methanesulfonamide |
Elastase 1 inhibitor |
DB03925 |
- |
ONO-6818 |
Elastase 1 inhibitor |
DB04184 |
- |
Acetate Ion |
Indicators and Reagents |
DB06951 |
- |
(3R)-3-ethyl-N-[(4-methylphenyl)sulfonyl]-L-aspartic acid |
|
DB07433 |
- |
(TERT-BUTYLOXYCARBONYL)-ALANYL-AMINO ETHYL-FORMAMIDE |
|
DB07955 |
- |
(2-BROMOETHYL)(2-'FORMYL-4'-AMINOPHENYL) ACETATE |
|
DB07956 |
- |
[1-(3-CHLORO-2-FORMYL-PHENYLCARBAMOYL)-2-METHYL-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER |
|
DB07957 |
- |
METHYL(2-ACETOXY-2-(2-CARBOXY-4-AMINO-PHENYL))ACETATE |
|
DB08007 |
- |
(2R)-3-{[(BENZYLAMINO)CARBONYL]AMINO}-2-HYDROXYPROPANOIC ACID |
|
DB08614 |
- |
3-[[(METHYLAMINO)SULFONYL]AMINO]-2-OXO-6-PHENYL-N-[3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPHENYL]-1(2H)-PYRIDINE ACETAMIDE |
|
DB08640 |
- |
(2S,3S)-3-FORMYL-2-({[(4-METHYLPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID |
|
DB08641 |
- |
(2S,3S)-3-FORMYL-2-({[(4-NITROPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID |
|